Shaping the Future of Healthcare 8:10 a.m. – 8:50 a.m. CT

Bill Frist

Senator Bill Frist is a co-founder and partner at Frist Cressey Ventures, where he serves on the boards of FCV partnership companies including Devoted Health and 180 Health Partners.  He is a heart and lung transplant surgeon, former U.S. Senate Majority Leader, and a partner at health services investment firm Cressey & Company. 

Senator Frist represented Tennessee in the U.S. Senate for 12 years and was elected Majority Leader in 2003. He led passage of the 2003 Medicare Modernization Act and the historic PEPFAR HIV/AIDS legislation that has saved millions of lives worldwide.    

As the founder and director of the Vanderbilt Multi-Organ Transplant Center, he performed over 150 heart and lung transplants, and continues to serve as an adjunct professor of surgery at the Vanderbilt University School of Medicine.   

Most recently, Senator Frist launched NashvilleHealth, a communitywide collaborative that works to improve the health of all Nashvillians. He is also the founder and co-chair of the Nashville Health Care Council Fellows initiative, which seeks to connect and educate the next generation of healthcare executives.   

Dr. Frist graduated from Princeton University and Harvard Medical School and completed surgical training at Massachusetts General Hospital and Stanford.  He has three sons and lives on a farm with his wife Tracy in Franklin, Tennessee. 

James Hildreth

James E.K. Hildreth, Ph.D., M.D.is the 12th president and chief executive officer of Meharry Medical College, the nation’s largest private, independent historically black academic health sciences center. Dr. Hildreth obtained a B.A. in chemistry from Harvard University and was selected as the first African-American Rhodes Scholar from Arkansas. He obtained a Ph.D. in immunology from Oxford University where his studies focused on the biology of virus-specific cytotoxic T cells. Dr. Hildreth also became an expert in monoclonal antibody technology and cell adhesion molecules while at Oxford. He obtained an M.D. from Johns Hopkins University School of Medicine and took a leave of absence from medical school for a postdoctoral fellowship in pharmacology at Johns Hopkins.

In 1987, Dr. Hildreth joined the Johns Hopkins School of faculty as assistant professor. He was appointed as the first associate dean for graduate studies at Johns Hopkins in 1994.In 2002, Dr. Hildreth became the first African American in the 125-year history of Johns Hopkins School of Medicine to earn full professorship with tenure in basic sciences. In July2005, Dr. Hildreth became director of the NIH-funded Center for AIDS Health Disparities Research at Meharry Medical College. In August of 2011, Dr. Hildreth became dean of the College of Biological Sciences at University of California, Davis. He was the first African-American dean in the university, which was founded in 1905. He was also appointed as a tenured professor in the Department of Cellular and Molecular Biology as well as professor in the Department of Internal Medicine in the UC Davis School of Medicine.

Dr. Hildreth’s research in immunology and virology, with a focus on HIV, has resulted in more than 130 publications in top journals and 11 patents. He has received numerous NIH grants to support his research including a prestigious NIH Director’s Pioneer Award. A technology developed by Dr. Hildreth was licensed by Genentech as the basis for the FDA-approved drug Raptiva.

Dr. Hildreth received numerous awards for his research, commitment to diversity in medicine, biomedical research and service to communities. His recognitions include honorary degrees, induction into the Arkansas Black Hall of Fame, the Johns Hopkins University Society of Scholars and election to the Institute of Medicine(now the National Academy of Medicine), part of the National Academy of Sciences. He was recently named “Nashvillian of the Year” by Nashville Scene magazine his leadership in the COVID-19 pandemic response and one the “Fifty Most Influential Clinical Leaders” by Modern Healthcare.

Dr. Hildreth has been appointed to two FDA advisory committees: Vaccines and Related Biological Products Advisory Committee(VRBPAC) and Antimicrobial Drugs Advisory Committee (AMDAC), these panels reviews COVID-19 vaccines and drugs respectively for approval. In February of 2021, he was appointed by President Biden to the COVID-19 Health Equity Task Force. Dr. Hildreth has served on numerous national advisory boards including the Harvard University Board of Overseers. He currently serves on the Advisory Council to the NIH Director, as chair of the Veteran’s Administration National Academic Affiliations Council and the board of directors of the Association of Academic Health Centers. Dr. Hildreth serves on several other boards including chair of the board of the St. Jude Children’s Research Hospital Graduate School of Biomedical Sciences.

Innovation and Disruption 9:00 a.m. – 10:15 p.m. CT

Aaron Gani

Aaron Gani is the founder and CEO of BehaVR, Inc., creating digital therapeutics for mental and behavioral health through the unmatched psychological power of Virtual Reality. Gani has been creating applications and experiences with technology throughout his career in healthcare and financial services, up to and including serving as Chief Technology Officer of Humana, a Fortune 50 managed care organization.

After a decade+ in healthcare leading technology development of population health, utilization management, disease management programs, pharmacy benefit management, primary care, urgent care, Health IT, and clinical analytics, and constantly working on ways to improve and empower consumer health with technology, data and analytics, Gani identified the crucial gap between knowledge, tools, and activations for improving mental and behavioral, and believes Virtual Reality experiences can close that gap.

Gani is a founding member of the Strategic Advisory Board of the Digital Medicine (DiMe) Society, and a founding advisory board member of the International Virtual Reality Healthcare Association (IVRHA). Gani holds a Master’s in Predictive Analytics from Northwestern University, an MBA, General Management and Health Sector Management from Duke University’s Fuqua School of Business, and a BS in Management/CIS from the University of Louisville.

Kyle Wailes

Kyle Wailes has served as Wellvana’s Chief Executive since January of 2022. Prior to joining Wellvana, Mr. Wailes was the Chief Financial Officer of SmileDirectClub, a global leader in tele-dentistry, where he played an essential role in the startup’s success, along with their IPO in 2019. Prior to SmileDirectClub, Mr. Wailes was with Intermedix, a leading provider of technology-enabled services for over 15,000 health care providers, where he served in different leadership capacities beginning in 2012, including as Executive Vice President of Physician Services from 2015-2017, and Chief Financial Officer from 2017 to 2018. Prior to joining Intermedix, Mr. Wailes started his career in healthcare private equity and healthcare investment banking, focusing on health care services and health care information technology companies.  

Mr. Wailes graduated from Brown University with a bachelor’s degree in pre-medicine and neuroscience and holds an M.B.A. from the Kellogg School of Management at Northwestern University. Mr. Wailes lives in Nashville, Tennessee with his wife and three kids. 

Marc Watkins

Dr. Marc Watkins, MSPH, FACOEM is the Chief Medical
Officer of Kroger Health, the healthcare arm of The Kroger Co., which comprises more than 2,200 pharmacies in 37 states and Washington D.C., more than 220 locations of The Little Clinic in nine states, as well as 11 specialty pharmacies across the country. Working with a cross functional team of pharmacists, nurse practitioners, physician assistants, dietitians, and technical care providers, he helps to develop the strategic direction and overall clinical program initiatives for our providers and delivers clinical guidance for associate benefit design. He is also responsible for
regulatory and accreditation requirements, maintaining a comprehensive suite of high-quality care for patients. Since the outbreak of COVID-19, he has also advised the company on its response, including testing and vaccination efforts.

Dr. Watkins joined Kroger in 2015 as Vice President and Medical Director of The Little Clinic. In August of 2018 he was promoted to Chief Medical Officer of Kroger Health. Prior to joining Kroger, he spent six years with Concentra Health Services in various physician leadership roles, providing strategic, operational, and clinical program development to major employers across the country.

Dr. Watkins is a fellow of the American College of Occupational & Environmental Medicine. He served five years active duty in the Navy as Senior Medical Officer and twice received the Navy Commendation Medal.

Dr. Watkins graduated with a Bachelor or Arts in philosophy from Holy Cross and received his M.D. and Master of Science in public health from Meharry Medical College, a historically black medical school.

Marcus Whitney

From college-dropout, waiter to self-taught, successful entrepreneur. 

Marcus Whitney is Founding Partner of Jumpstart Health Investors, the most active venture capital firm in America focused on innovative, healthcare companies with a portfolio of over 150 companies. He recently launched Jumpstart Nova, the first healthcare venture fund in America investing exclusively in Black founded and led startups. 

Marcus is also co-founder and minority owner of Major League Soccer team, Nashville Soccer Club. 

Marcus is the author of the Amazon #1 best-selling book “Create and Orchestrate”, about claiming your Creative Power through entrepreneurship. His work has been featured by Entrepreneur, CNBC, Inc., NPR, Fast Company, and The Atlantic.  

Marcus is a member of the board of Celtic Bank, the Country Music Hall of Fame® and Museum, the Nashville Convention and Visitors Corporation, Instruction Partners, OZ Arts and Launch Tennessee. 

Robin Shah

Robin Shah is the Founder and Chief Executive Officer of Thyme Care, a value-based oncology management platform that provides personalized, clinically coordinated care to individuals with cancer. Thyme Care pairs human guidance with software and analytics to engage members with a cancer diagnosis, quickly connect them to the right care, and provide ongoing support through targeted, evidence-based interventions.  

Before launching Thyme Care, Robin was a founding member of OneOncology, where he served as the Chief Development and Marketing Officer, focusing on provider development, marketing, strategy, and technology/analytics. Prior to OneOncology, Robin’s passion for building a stronger future for community oncology brought him to Flatiron Health, a leading healthcare technology company. There, Robin served as Vice President of provider marketing and strategy, where he focused on developing successful go-to-market strategies for patients and providers. Before joining Flatiron, Robin helped manage a comprehensive community cancer center in his hometown, Gettysburg, PA. Robin was instrumental in securing a strong future for the cancer center by restructuring the practice’s business operations, implementing leading technologies, and helping to build a robust research program, ultimately creating a better experience for patients in his community.  

Robin earned his bachelor’s degree in biomedical engineering from George Washington University and holds an M.B.A from the Carey Business School at Johns Hopkins University. 

 

New Models of Care Session 10:30 a.m. -11:45 a.m. CT

Lindsay Jurist-Rosner

Lindsay Jurist-Rosner is the CEO of Wellthy, Inc. based in New York City. Wellthy is helping the 66 million Americans who care for aging, chronically ill, and disabled loved ones. With Wellthy, Lindsay is building the company she needed throughout the 28-years caring for her mother.  

Prior to founding Wellthy in 2014, Lindsay was in the advertising technology and media industries with functional responsibilities in marketing, product and sales. Lindsay served as the Senior Vice President of Marketing at NY-based advertising technology startup, Simulmedia. Before that, Lindsay ran Marketing Research at Machinima; worked in product and strategic marketing at Microsoft; worked in marketing at LA-based startup, Spot Runner; and ran the west coast advertising and marketing relationships for The Atlantic.  

Lindsay received an MBA from the Harvard Business School and a BA in Economics-Operations Research from Columbia University. Lindsay lives in New York City. 

Michael Uchrin

Michael Uchrin is an accomplished senior healthcare executive who is the CEO & Co-Founder of Monogram Health, a next-generation, value-based chronic condition risk provider serving patients living with chronic kidney and end-stage renal disease and their related metabolic disorders. 

Prior to co-founding Monogram Health, Michael led the growth of Health Choice, the managed care and insurance business unit of private equity sponsored IASIS Healthcare (Acquired by Blue Cross Blue Shield of Arizona) from a small Arizona Medicaid plan into a robust regional managed care organization operating five health plans and two accountable care networks. Under Michael’s leadership, Health Choice grew to more than 650,000 distinct Medicaid, Medicare, and commercial members through its health plans, integrated delivery networks, and managed care solutions for self-insured employers.

Michael holds a Master of Business Administration from the W.P. Carey School of Business at Arizona State University, a Master of Engineering in Software from the Ira A. Fulton School of Engineering at Arizona State University, and a Bachelor of Science in Geosciences (Geophysics Concentration) from the University of Arizona.  Away from professional career activities, Michael enjoys time with his wife Alison, and their two children, Andrew, and Megan. He also loves to golf, surf, and snowboard.  

Mike Edgeworth

Dr. Edgeworth is a neurologist and Chief Population Health Officer at Octave, a healthcare innovation company that has developed a precision care solution for patients with multiple sclerosis.  He has over two decades of experience as a physician leader and is focused on partnering with health plans and other at-risk entities to deliver Octave’s innovation as a total cost of care solution for their members with this complex, high-cost disease.  

Prior to Octave, Mike spent seven years at Cigna where he was a National Senior Medical Executive responsible for medical trend and affordability, clinical program innovation and value-based provider partnerships. While at Cigna, he continued to practice neurology as a tele-neurologist serving patients in rural communities who lacked specialty care access.  Prior to Cigna, Mike spent ten years in clinical neurology practice, including an academic appointment at Vanderbilt University and serving as Chairman of the Department of Medicine in his community-based hospital.  Mike completed his neurology residency and fellowship training at Vanderbilt University, where he also obtained a Master of Science in Clinical Investigation.  He attended the University of Mississippi for medical school and has a BS in Chemistry from Mississippi State University.  

Ryan Donelly

Ryan Donnelly is a healthcare executive with nearly 15 years of experience focused on services and payer/provider HCIT. He has a strong growth, strategy and product focus, with extensive private equity and public policy expertise. Donnelly is head of strategy and innovation at Premise Health, the world’s leading direct healthcare company and one of the largest digital providers in the country, serving over 11 million eligible lives across the largest commercial and municipal employers in the U.S. Premise operates more than 800 wellness centers in 45 states and Guam, and provides virtual care nationwide.   

In addition to leading strategy and innovation, Donnelly built and runs Premise’s value-based care product suite, Connected Care+, which is focused on reducing costs and improving outcomes for commercial populations.  He also shares responsibility for key enterprise partnerships as well as mergers and acquisitions.  

Before joining Premise Health, Donnelly was a principal at Kingfish Group, a private equity investment and strategy consulting firm in San Francisco, where he led all healthcare investing, consulting and industry research initiatives. Prior to Kingfish Group, Donnelly was a healthcare investment banker for Citigroup in New York. Earlier in his career, Donnelly worked at the Botswana International Financial Services Center, and the U.S. Senate. In addition, he is an alumnus of the Nashville Health Care Council Fellows and Coro Fellows programs.   

Donnelly earned a M.S. from Carnegie Mellon University and a B.A. from Providence College, where he was class president and played Division 1 lacrosse. He is currently pursuing a M.S. in Global Healthcare at the University of Oxford. He lives in Nashville, TN with his wife, Pippa, daughter, Adelaide, and French Bulldog, Clementine.

AI in Healthcare 12:00 p.m. – 1:00 p.m. CT

Edmund Jackson

Dr. Edmund Jackson is the Chief Data Scientist at Whistler Capital Partners. Edmund’s focus is the implementation of data analytics and AI at Whistler Capital’s portfolio companies to improve the quality and effectiveness of healthcare. In this role, Edmund not only applies data techniques to support the identification of potential investments but also works actively with portfolio companies to create and execute their data and AI strategies to drive better access, experience and cost. 

Prior to joining Whistler Capital, Edmund served as the Chief Data Scientist of HCA Healthcare, a role in which he worked for 8 years applying data science to the challenges of the largest private healthcare company. Edmund’s teams created many data science products which were broadly applied with HCA saving thousands of lives and generating significant financial and operational efficiencies. Edmund is proud of SPOT, a data science-enabled sepsis workflow, which won several industry awards and continues to save lives daily. His team’s signature product at HCA is NATE, a real-time, AI-enhanced digital twin of the HCA system which enables a diverse set of workflows from emergency response, to discharge planning to clinical decision support. 

His early career was in the London hedge fund industry where he worked as a quantitative manager designing, creating, and running trading and portfolio optimization algorithms. Edmund also formed a data science consulting company in Cambridge. 

Edmund’s education comprises a BSc (summa cum laude), an MSc (cum laude) from the University of Natal in South Africa, and a Ph.D. from the University of Cambridge in England where his doctoral research focused on the creation and application of advanced statistical techniques in medical research. 

James Lakes

James Lakes is the Sr. Vice President of the Healthcare and Life Science Providers organization at Salesforce. He leads the sales team supporting 7,800+ healthcare organizations across the United States. In his previous leadership roles at Microsoft (16 years) and VMware (2.5 years), he served as a Change Agent and Leader scaling up businesses as large as $1.1B, 500+ associates and approximately 5,000 customers. James has been working in the IT, Management Consulting, and Health IT industry for nearly 25 years in the United States and Europe.  
 
James is a graduate of Copenhagen Business School with a M.Sc degree in International Business & Strategy. He is also an inaugural graduate of the Nashville Health Care Council Fellows Initiative Program led by former Senate Majority Leader Dr. Bill Frist. 
 
His goal at Salesforce is to build the world’s best hybrid-cloud and digital transformation team, capable of enabling and empowering customers and partners during organizational, digital, and data transformation journeys. 

Shobhit Varshney

Shobhit is a Partner in IBM Consulting and leads the Artificial Intelligence practice across all industries in US, Canada and Latin America. He is a trusted advisor to c-suites and a recognized global leader in applying AI & Analytics to transform businesses. He has 15 years of proven track record of partnering with fortune 100 global brands on their Intelligent Enterprise journey, and holds multiple AI patents. While helping organizations adopt AI responsibly, he advocates for explainability, fairness, robustness, transparency, and privacy for ethical AI. He has been recognized as a global thought leader in AI & Analytics wining multiple industry awards. 

Prior to joining IBM, Mr. Varshney gained experience in strategy consulting and deploying analytics in various domains ranging from bio-medicine, financial services and technology at Bain & Co, Bloomberg and Intel. Shobhit earned his Bachelors in Computer Engineering and Math with summa cum laude from University of Arkansas, Masters in Computer Science and BioMedicine from Cornell University, and an MBA with distinction from Johnson at Cornell. 

Private Equity and Investments 1:00 p.m. – 2:15 p.m. CT

Charles Byrge

Mr. Byrge directs Harpeth Capital’s principal investing, venture capital and fund placement business.  He has over 30 years of experience with investing, capital raising and advising on M&A transactions for middle market companies.   

Prior to joining Harpeth Capital, he was a Senior Managing Director and Head of Investment Banking at FTN Financial Securities, where he was involved in opening and directing the New York and Nashville offices. Prior to that, he was Managing Director of Mergers and Acquisitions at SunTrust Equitable Securities (now Truist Securities), where he directed a wide variety of assignments for both public and private companies. Previously, Chuck was a senior member of the M & A Department at Morgan Keegan & Co. and Vice President at NationsBanc Capital Markets in Dallas where he co-directed the M&A practice for the Southwestern U.S.  He is a Chartered Financial Analyst and a former Certified Public Accountant with Peat Marwick and Ernst & Young. 

Chuck received a BA in Economics from Vanderbilt University and an MBA from the Owen Graduate School of Management at Vanderbilt University. He has served on the Alumni Board of Directors and is currently a member of the Emeritus Board for Owen Graduate School of Management. 

Chuck serves on the Board of CaringWays, Polaris Health, HomeFirst Home Healthcare, First Honey and the Nashville Health Care Council’s Fellows Alumni Board. He is also a member of the Advisory Board for Mainsail Group.  Previously he served on the Board of the Nashville Healthcare Council and is an alumni of their Fellows program.  He is also a former Board member of the Boy Scouts of America Middle Tennessee Council and the Nashville Sports Council. 

David Pontius

Mr. Pontius received his Bachelor of Science in Business Administration from The University of North Carolina at Chapel Hill. Prior to joining WindRose Health Investors in 2008, Mr. Pontius worked in the Healthcare Investment Banking Group of Oppenheimer & Co. (formerly CIBC World Markets), where he focused on strategic advisory, mergers and acquisitions and public and private company financings. Mr. Pontius currently serves on the board of directors of MDsave,  Shearwater Health, Traditions Behavioral Health, Healthmap Solutions and Workplace Options.

Devin Carty

Devin has worked as a biologist and biochemist with NASA, built medical clinics in the jungles of Congo, Africa, and pursued healthcare solutions as an entrepreneur, venture capitalist, and hospital system operator. 

Devin serves as the CEO of Martin Ventures, a healthcare-focused venture capital firm, where he leads the investment committee and oversees the partnership with the 25+ portfolio companies. Additionally, Devin has co-founded several companies including, Reimagine Care, Wellvana, Trilliant Health, and Clariture Health.  

Prior to Martin Ventures, Devin served as executive vice president, chief talent officer, and chief strategy officer for Cancer Treatment Centers of America. He oversaw the organic and M&A growth strategy while advancing the culture, increasing employee engagement to the 93rd percentile, and enhancing the patient experience, earning an NPS score of 96. 

Prior to Cancer Treatment Centers of America, Devin was at Vanguard Health Systems, serving as the corporate chief experience officer and chief marketing officer. Devin was part of the team that grew Vanguard to 29 hospitals, 46,000 employees, and $6.5 billion in revenue. Vanguard had a public offering in 2011 and sold the company to Tenet for $4.3 billion in 2013.  

Before Vanguard Health Systems, he was in management consulting at Gallup. Devin served as a partner on the healthcare team. He was a trusted advisor to some leading healthcare systems on human resources, M&A, and change management. 

Devin began his career as a scientist, biologist and biochemist, with NASA. His research centered around the effects of vibration on bacterial growth and antibiotic resistance.  

Geoffrey Clark

Geoffrey Clark is a Managing Partner at Whistler Capital Partners (“WCP”), a Nashville-founded and based private equity firm focused on control-oriented growth equity and growth buyouts in the healthcare industry and related tech-enabled services platforms. Prior to forming WCP in 2021, Geoff was the Senior Managing Director of Starr Investment Holdings LLC (“SIH”), which was a Nashville and New York-based private equity firm affiliated with the Starr Companies. Geoff joined the Starr Companies in 2007 and SIH was subsequently formed in 2012. Prior to joining Starr, Geoff spent over a decade at Goldman, Sachs & Co. in New York where he was a Partner and Managing Director.  Geoff graduated with a Bachelor of Commerce from the University of British Columbia as a Leslie Wong Fellow, and is a Chartered Financial Analyst. Geoff lives with his wife and four children in Nashville, Tennessee.

Leadership in Health Care 2:30 p.m. – 4:00 p.m. CT

Michael Burcham

Michael Burcham is an entrepreneur, investor and health care strategist with 30 years’ experience leading technology-enabled healthcare organizations. 

Burcham is an executive partner with Shore Capital, a micro-cap investment firm based in Chicago, IL. He began working with Shore Capital in 2011.  

Burcham also serves on faculty at Vanderbilt University where he teaches Health Care Innovation and Launching New Ventures in the Owen Graduate School of Management. 

Previously, Burcham was the founder and CEO of Narus Health, a transformational health care concierge organization serving self-insured employers. Founded in 2015, the company became part of Lucent Health in 2019. 

Prior to forming Narus Heath, Burcham was the founding president and CEO of the Nashville Entrepreneur Center, serving in that capacity from 2010-2015. Burcham served as the co-chair of the national advisory council on innovation and entrepreneurship for the U.S. Secretary of Commerce from 2014-2016. 

From 2000-2007, Burcham served as president of ParadignHealth. ParadigmHealth specialized in the management of clinically complex patients and is now part of Optum Health. 

From 1993 – 2000, Burcham was president and founder of Theraphysics, a venture-backed, specialty rehabilitation firm. Theraphysics was acquired by Beverly Enterprises in 1998. 

Burcham began his career at Hospital Corporation of America after graduating from the University of Mississippi Medical Center in 1983. Burcham also holds an MBA from Belmont University and a Doctorate in Health Administration from the Medical University of South Carolina

Rusty Holman

Rusty is the founder of 1821Health, a healthcare leadership development company with a vision of “Inspiring dramatic improvements in healthcare by embracing the workforce as our most treasured asset.” His passion for developing leaders and shaping organizational culture are hallmarks of his 25+ years as a physician executive.  

Rusty’s leadership has been integral to three health system mergers and ownership changes involving academic, non-profit, venture capital, private equity and publicly traded entities. Most recently, he was chief medical officer for LifePoint Health, a national health system comprised of 89 hospitals in 30 states, where he led the organization to win the John M. Eisenberg Award for Innovation in Patient Safety and Quality. Previously, Rusty was chief operating officer and chief clinical officer of Cogent Healthcare, a provider of hospital medicine and critical care solutions in over 120 locations in 28 states. He began his career as faculty at the University of Minnesota and medical director of hospital services for HealthPartners, where he oversaw health system quality, physician leadership development and founded one of the nation’s first hospitalist programs. 

Rusty has served as Past-President of the Society of Hospital Medicine, founder of the SHM Leadership Academies, is a Nashville Healthcare Council Fellow, voted a Top 50 Physician Executive for Modern Healthcare, and is an author and co-editor of the textbook, Comprehensive Hospital Medicine. His frequent speaking engagements have included the Institute for Healthcare Improvement, Society of Hospital Medicine, American Hospital Association, and the American College of Healthcare Executives, among others. Rusty brings a pragmatic and inclusive approach to advance healthcare leadership as the lynchpin to confronting change, empowering the workforce, and meeting the dire imperative to improve our industry.